On the other hand, inhibition of cathepsin S significantly decreases the response to antigens, and cathepsin S has been proposed as a therapeutic target for diabetes and certain auto-immune diseases such as asthma and psoriasis [86]. The gene discussed is CTSS; the disease is psoriasis.